Abstract

POTENTIAL OF STEM CELL THERAPY IN TREATMENT OF PARKINSON’S DISEASE

Suchita S. Chaudhari*, Sharayu U. Rajput, Pranita V. Patil and Jyoti Kedar

Abstract

Parkinson’s disease is slow developing dopaminergic disorders which shows asymmetric or unilateral motor symptoms. Dopaminergic therapies are widely used in the treatment of Parkinson’s disease. In these article we have studied various human embryonic stem cell method. Embryonic stem cell extracted from mouse blastocyst mainly were used. various types of stem cells are being used’s. We have also started methods and characteristics of the embryonic stem cell. Human induced pluripotent cells were shown promising activity against parkinson’s disease in various clinical trials. The embryonic stem cells therapy has various problem including the monitoring of therapy and requiring the clinical permission for the safe. Totipotency which is one of the major properties of the embryonic stem cell can be prove as the evolutionary for the treatments of various disease like AIDS, cancer, Parkinson’s disease and other chronic disorders. Animal trials have been performed by using embryonic stem cells, and has shown promising results. Clinical trials are being doing right now and also showing much promising results. In future embryonic stem cell therapy right prove as the promising and safer way to procure the deadly chronic Parkinson’s disease like conditions.

Keywords: Parkinson’s disease, Embryonic Stem Cell, Human Embryonic Stem Cell Mesenchymal cells, Neural stem cell.